| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 0.0004 |